ManagedCareCGM

This site is intended for managed care professionals in the U.S.

This site is intended for managed care professionals in the U.S.

Professionals in Canada should visit CanadaCGM.com

Continuous Glucose Monitoring

Education for Managed Care, Pharmacy, and Payer Professionals

Register Now for a Live CE Webcast

The Value of Streamlined Coverage for Real-Time CGM to Optimize Outcomes and Resource Utilization for Members with Diabetes

Jointly provided by Impact Education, LLC and Medical Education Resources, Inc.

This activity is supported by an independent educational grant from Dexcom, Inc.

Medical Education Resources

 

 

 

Monday, June 27, 2022
11:30am to 1pm ET

The on-demand CE archive of this live webcast is available at:

https://www.managedcarecgm.com/rtcgmoutcomes/

 

Learn About
  • The latest data supporting the use of real-time CGM (rtCGM) and how it improves patient outcomes
  • How diabetes technology increases patient engagement and self-management across diverse member populations
  • The positive impact of electronic prior authorization for rtCGM under the pharmacy benefit  Expert Faculty Presenters
Expert Faculty Presenters
Dana McCormick, RPh, FAMCP
Director of Pharmacy
Blue Cross Blue Shield of Texas
Samir Mistry, PharmD, MBA
Vice President of Pharmacy Strategy & Services
Capital Blue Cross
Monica Peek, MD, MPH
Professor of Medicine
Associate Director, Chicago Center for Diabetes Translational Research
The University of Chicago Medicine

Kelly L. Close
Founder, The diaTribe Foundation
President, Close Concerns


Who Should Attend

The primary target audience for this initiative consists of medical directors, registered nurses, pharmacy directors, clinical pharmacists, specialty pharmacists, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations.

Statement of Need/Program Overview

The true impact of diabetes-related severe hypoglycemia (SH) events is often underestimated by payers, with only approximately 5% of self-reported events among pharmacologically treated patients being captured by health care utilization-based surveillance. Continuous glucose monitoring (CGM) represents a significant advancement in the precision management of type 2 diabetes (T2D), providing members from diverse demographics, including minority populations, with the ability to receive a virtually uninterrupted stream of information about the current physiology of their disease. However, many providers cite that prior authorizations may delay treatment and negatively impact clinical outcomes. A smart edit featuring an automated look back in claims data for a previous insulin prescription can be used as the criterion for approval with real-time adjudication, easing the administrative burden for payers and providers and streamlining access for members. This approach serves as a basic blueprint for payers to apply the latest evidence in advancing T2D management with optimal outcomes and cost reduction.

Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate improved ability to:

  • Review the latest data supporting the use of rtCGM to improve patient outcomes and reduce resource utilization in T1 and T2D
  • Assess the impact of social determinants of health (SDOH) on outcomes in diabetes among low-income and racial/ethnic minority populations
  • Describe the role of diabetes technology in increasing patient engagement and self-management across diverse member populations of varying age, race/ethnicity, income, and insurance type
  • Discuss the positive impact of electronic prior authorization for rtCGM under the pharmacy benefit in terms of provider administrative burden, access, and total cost of care
Agenda

Date and Time
Monday, June 27, 2022
11:30am to 1pm ET

Welcome and Introduction
Dana McCormick, RPh, FAMCP
The Latest Findings Demonstrating Improved Outcomes and Reduced Resource Utilization with rtCGM in T1 and T2D
Monica Peek, MD, MPH
Real-Time Continuous Glucose Monitoring Case Scenarios and Follow-up Panel Discussions

  • Enhancing Patient Engagement and Self-Management
  • Addressing SDOH in Comprehensive Diabetes Programming
  • The Role of Streamlined Coverage and Access in Timely and Effective Care

Dana McCormick, RPh, FAMCP; Monica Peek, MD, MPH; Samir Mistry, PharmD, MBA; Kelly L. Close

Audience Q&A Session
Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
Adjournment
Accreditation Information

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Impact Education, LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Medical Education Resources designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

Medical Education Resources designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA0003680-9999-22-007-L01-P

Type of Activity: Knowledge

Continuing Nursing Education

Medical Education Resources designates this live activity for a maximum of 1.5 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.

Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.

Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
No additional fee is required to attend this CME/CPE activity.

If you have any questions, please call (215) 619-8812 or email info@impactedu.net.

PHP Code Snippets Powered By : XYZScripts.com